BPC-157, also known as Body Protection Compound-157, is a pentadecapeptide (a 15-amino acid peptide sequence) first described in 1992
It boosts collagen and elastin production, smooths fine lines, and enhances healing at the cellular level
[PMID: 9102927] PubMed record related to this compound for laboratory literature review
All medications we provide for Baltimore patients meet strict safety and quality standards
In the large cardiovascular outcomes trial reported in the Wegovy label, systolic blood pressure fell by a mean of 3.8 mmHg with semaglutide versus 0.5 mmHg with placebo at week 104, a difference of 3.3 mmHg from a baseline of 131 mmHg
There is no recommended daily allowance for sulfur, and a lack of sulfur doesn't cause a known condition